View Author
patient limb perfusion tumor sarcoma perfusion response tm-ilp recurrence necrosis resection tissue disease survival factor month extremity oncol tissue sarcoma tumor necrosis factor melphalan result progression melanoma 1·00 treatment amputation tissue sarcomas radiotherapy cancer surgery adjuvant study prognostic control signi analysis metastase r 0 resection stage adjuvant rtx recurrence rate range follow-up eggermont society group in-transit oncology oncology information downloaded table surgery society ltd ann surg oncol van geel response rate unifocal in-transit metastases prognostic factors american society extremity sts disease-speci fic survival melanoma in-transit metastases therapy erasmus mc american series j clin oncol john wiley medische bibliotheek adjuvant radiotherapy toxicity disease-speci tnf -α margin british journal leakage iiiab ficant wieberdink stage iv disease
4 Most Recent Publications
|
Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
(Article)
Deroose, J.P. Grünhagen, D.J. Geel, A.N. van Wilt, J.H.W. de Eggermont, A.M.M. Verhoef, C. |
2011-11-01
|
|
Long-term results of tumor necrosis factor α- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas
(Article)
Deroose, J.P. Eggermont, A.M.M. Geel, A.N. van Burger, J.W.A. Bakker, M.A. den Wilt, J.H.W. de Verhoef, C. |
2011-10-20
|
|
Hepatic steatosis is not always a contraindication for cadaveric liver transplantation
(Article)
Deroose, J.P. Kazemier, G. Zondervan, P.E. IJzermans, J.N.M. Metselaar, H.J. Alwayn, I.P.J. |
2011-06-01
|
|
Radiotherapy for Soft Tissue Sarcomas after Isolated Limb Perfusion and Surgical Resection: Essential for Local Control in All Patients?
(Article)
Deroose, J.P. Burger, J.W.A. Geel, A.N. van Bakker, M.A. den Jong, J.S. de Eggermont, A.M.M. Verhoef, C. |
2010-01-01
|
